Tuesday, May 21, 2013
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Discovery
1 of 2
Previous |
Next
Discovery
When two heads are better than one
According to PA Consulting’s Jan Malek, R&D president isn’t one job – it’s two. Maybe it’s time to create a new position …
No Comments
LIMS: An Inside Perspective
Karl Yorgey works with the GPCD in the pre-clinical organization for Johnson & Johnson, supporting all of the GLP applications within preclinical. Thermo Electron Corporation’s LIMS, Watson, is one such application.
No Comments
Technical study: battle at the gates – combating mutant kinases
Molecular therapeutics that target proteins kinases represent a major advance in the treatment of disease, particularly cancer.
No Comments
Technical study: robust calcium mobilization
Robust calcium mobilization by a broad range of overexpressed GPCRs in cell lines containing endogenous promiscuous G proteins
No Comments
1 of 2
Previous |
Next
Source: www.ngpharma.com© 2013 GDS Publishing Ltd. All rights reserved.